NCPA's qAM

qAM

FDA issues rare Class 1 recall

by NCPA | Feb 13, 2020

The FDA has issued a Class 1 recall of Medtronics' MiniMed Insulin Pumps due to incorrect insulin dosing. A Class 1 recall is the FDA's most serious recall, reserved for products that have caused grave injury or death. One death has been linked to the pump. Details on the recall can be found here.